Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDASANUTLIN: 74 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
74
Total FAERS Reports
11 (14.9%)
Deaths Reported
54
Hospitalizations
74
As Primary/Secondary Suspect
10
Life-Threatening

First Report: 20160525 · Latest Report: 20231008

What Are the Most Common IDASANUTLIN Side Effects?

#1 Most Reported
Thrombocytopenia
19 reports (25.7%)
#2 Most Reported
Neutropenia
19 reports (25.7%)
#3 Most Reported
Febrile neutropenia
17 reports (23.0%)

All IDASANUTLIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Neutropenia 19 25.7% 0 12
Thrombocytopenia 19 25.7% 3 14
Febrile neutropenia 17 23.0% 0 17
Diarrhoea 6 8.1% 0 6
Platelet count decreased 6 8.1% 0 4
Sepsis 5 6.8% 3 5
Septic shock 5 6.8% 3 4

Who Reports IDASANUTLIN Side Effects? Age & Gender Data

Gender: 39.0% female, 61.0% male. Average age: 61.2 years. Most reports from: FR. View detailed demographics →

Is IDASANUTLIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2016 15 0 15
2017 8 5 6
2018 16 2 15
2019 15 2 6
2020 3 1 2
2021 2 0 2
2022 3 0 1
2023 7 1 7

View full timeline →

What Is IDASANUTLIN Used For?

IndicationReports
Acute myeloid leukaemia 35
Diffuse large b-cell lymphoma 9
Neuroblastoma 8

Official FDA Label for IDASANUTLIN

Official prescribing information from the FDA-approved drug label.